Nerve Growth Factor
Osteoarthritis may be 'inherently' tied to neuroplasticity
DESTIN, Fla. — “Sprouting” of new nerve endings in certain areas of the knee could be a key to understanding osteoarthritis and developing new treatments, according to a speaker at the Congress of Clinical Rheumatology East.
BLOG: Neurotrophins hold the key to unlock diseases of the brain, eye
As a neuroscientist, biochemist and molecular biologist, I’m interested in the biosynthesis and regulation of neurotrophic factors, including nerve growth factor and brain-derived neurotrophic factor.
‘Appreciating neuroplasticity’ may be key to developing effective osteoarthritis therapies
SAN DIEGO — The key to developing effective therapies for the management of osteoarthritis may lie in appreciating neuroplasticity in patients with the disease, according to a speaker at the Congress of Clinical Rheumatology West.
Specialists share pearls on using cenegermin, selecting patients
Eye drops containing a novel recombinant human nerve growth factor can now be used in U.S. patients to treat neurotrophic keratitis, a rare disease for which no treatment was previously available.
VIDEO: ‘Mind-shattering’ potential of gene therapy for neurotrophic keratitis
In this video, Clark Chang, OD, a part of the corneal team at Wills Eye Hospital in Philadelphia and director of Global Medical Affairs at Glaukos, speaks with Healio about treatment options for neurotrophic keratitis currently in the pipeline.
VIDEO: ‘Exciting’ conference updates in neurotrophic keratitis
In this video, Clark Chang, OD, a part of the corneal team at Wills Eye Hospital in Philadelphia and director of Global Medical Affairs at Glaukos, highlights neurotrophic keratitis updates from recent conferences.